
Pharmaceutical Research
Drug discovery, preclinical research, and the development of new therapeutic approaches.

Biotechnology Investments
Biotechnology connects scientific discovery with new approaches to health, food and industry — a field where careful research can translate into meaningful long-term progress.
Blubeard Investment AG approaches biotechnology opportunities with respect for scientific complexity, attention to development pathways, and a patient, long-term perspective.
Investment sector · 6 areas of focus
Scrollto the overviewBiotechnology Perspective

Evaluating biotechnology requires an understanding of the underlying science, the stage of development, and the regulatory and clinical steps that lie between research and application.
Our perspective considers both scientific merit and practical realities — the capabilities of a team, the strength of its platform, and the long horizons that characterise life-science innovation.
Areas of Focus
Areas of investment interest — not a list of holdings or transactions.
Investment Considerations
Biotechnology opportunities involve scientific uncertainty, long development timelines, and demanding regulatory standards that require careful, informed evaluation.
01 / 04Scientific & Clinical Validation
Long-Term Perspective
Advances in biology continue to reshape how diseases are understood, how food is produced, and how materials are made.

Our perspective recognises that the most meaningful progress in biotechnology often unfolds over many years — and that understanding this horizon is essential to evaluating its long-term potential.
Biotechnology Inquiries
Connect with Blubeard Investment AG to explore strategic discussions related to life sciences, biotechnology research, and long-term innovation.
